Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

D-Pharm Ltd
Kiryat Weizmann Science Park Bldg 7PO Box 2313
Rehovot,  IS  76123
Israel
Telephone: 972-8-9385100
Fax: () 972-8-9300795
URL: http://www.dpharm.com
Email: info@dpharm.com

D-Pharm Limited, founded in 1993 and based in Rehovot, Israel, develops lipid-based drugs that treat nervous system disorders, cancers, and autoimmune diseases. The firm's DP-VPA epilepsy and DP-b99 stroke therapies are in clinical trials. The company also is developing Alzheimer's disease products. D-Pharm employs its proprietary Membrane Active Chelators (MAC), Regulated Activation of Prodrugs, or RAP (TM), and LipidoMimetix (TM) platforms in optimizing drug development processes. The MAC platform uses lipids to develop small molecule drugs. RAP chemically links lipid vectors to active drug sites, supporting the creation of inactive prodrugs. The drugs function within lipid environments of cell membranes. The firm holds over 75 international patents on its treatments. Investors include Care Capital, Morgan Stanley Venture Partners, Rho Ventures, Quintiles Transnational Corporation, Clal Biotechnology, Gemini Group, Denali, Apax, and Vertex. The company has raised over $50 million in funding. D-Pharm was founded by Dr. Alex Kozak.

Org. Type: Corporation Equity Type: Private
Company Status: Active Date Founded: 1993

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.